AAM’s Baeder Takes A Focused Approach To Articulating Industry Priorities
New Association Chair Says US Is At An ‘Inflection Point’ For Generics Sustainability
Christine Baeder, Teva’s chief operating officer for US generics and biosimilars, was named chair of the AAM’s board in February. Speaking with Generics Bulletin, she sets out her priorities against the backdrop of a US generics industry that is now at an “inflection point” for sustainability.
